+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

France Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others

  • PDF Icon

    Report

  • 50 Pages
  • October 2024
  • Region: France
  • GlobalData
  • ID: 6025148
Description Jump to:
The “France Orthobiologics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the France Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Orthobiologics, Cartilage Repair and Others

The France Orthobiologics Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Orthobiologics Market.
  • Global corporate-level profiles of key companies operating within the France Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

France Orthobiologics is segmented as follows:

  • Bone Grafts and Substitutes
  • Bone Growth Stimulators
  • Cartilage Repair
  • Soft Tissue Biologics
  • Viscosupplementation

Reasons to Buy

France Orthobiologics Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Orthobiologics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, France
3.1 Orthobiologics Market, France, Revenue ($m), 2018-2033
3.1.1 Bone Grafts and Substitutes Market, France, Revenue ($m), by Segment, 2018-2033
3.1.2 Bone Growth Stimulators Market, France, Revenue ($m), by Segment, 2018-2033
3.1.3 Cartilage Repair Market, France, Revenue ($m), by Segment, 2018-2033
3.1.4 Soft Tissue Biologics Market, France, Revenue ($m), by Segment, 2018-2033
3.1.5 Viscosupplementation Market, France, Revenue ($m), by Segment, 2018-2033
3.2 Orthobiologics Market, France, Volume (Units), 2018-2033
3.2.1 Bone Grafts and Substitutes Market, France, Volume (Units), by Segment, 2018-2033
3.2.2 Bone Growth Stimulators Market, France, Volume (Units), by Segment, 2018-2033
3.2.3 Cartilage Repair Market, France, Volume (Units), by Segment, 2018-2033
3.2.4 Soft Tissue Biologics Market, France, Volume (Units), by Segment, 2018-2033
3.2.5 Viscosupplementation Market, France, Volume (Units), by Segment, 2018-2033
3.3 Orthobiologics Market, France, Average Price ($) , 2018-2033
3.4 Orthobiologics Market, France, Distribution Share by Revenue ($m), 2023
3.5 Orthobiologics Market, France, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in France, Orthobiologics Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Sanofi
4.2.1 Company Overview
4.3 Stryker Corp
4.3.1 Company Overview
4.4 ZimVie Inc
4.4.1 Company Overview
4.5 Orthofix Holdings Inc
4.5.1 Company Overview
4.6 Fidia farmaceutici SpA
4.6.1 Company Overview
4.7 Bioventus Inc
4.7.1 Company Overview
4.8 Zimmer Biomet Holdings Inc
4.8.1 Company Overview
4.9 Smith & Nephew Plc
4.9.1 Company Overview
4.10 Ferring Pharmaceuticals AS
4.10.1 Company Overview
4.11 LifeNet Health Inc
4.11.1 Company Overview
4.12 Globus Medical Inc
4.12.1 Company Overview
5 Orthobiologics Market Pipeline Products
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Distribution Share Analysis
6.1.7 Benchmarking
6.2 the analyst Consulting
6.3 Contact the Publisher
6.4 Disclaimer
List of Tables
Table 1: Orthobiologics Market, France, Revenue ($m), USD Constant, 2018-2033
Table 2: Bone Grafts and Substitutes Market, France, Revenue ($m), USD Constant, 2018-2033
Table 3: Bone Growth Stimulators Market, France, Revenue ($m), USD Constant, 2018-2033
Table 4: Cartilage Repair Market, France, Revenue ($m), USD Constant, 2018-2033
Table 5: Soft Tissue Biologics Market, France, Revenue ($m), USD Constant, 2018-2033
Table 6: Viscosupplementation Market, France, Revenue ($m), USD Constant, 2018-2033
Table 7: Orthobiologics Market, France, Volume (Units), 2018-2033
Table 8: Bone Grafts and Substitutes Market, France, Volume (Units), 2018-2033
Table 9: Bone Growth Stimulators Market, France, Volume (Units), 2018-2033
Table 10: Cartilage Repair Market, France, Volume (Units), 2018-2033
Table 11: Soft Tissue Biologics Market, France, Volume (Units), 2018-2033
Table 12: Viscosupplementation Market, France, Volume (Units), 2018-2033
Table 13: Orthobiologics Market, France, Average Price ($), 2018-2033
Table 14: Orthobiologics Market, France, Distribution Share by Revenue ($m), USD Constant, 2023
Table 15: Orthobiologics Market, France, Company Share by Revenue ($m), USD Constant, 2023
Table 16: Orthobiologics Market Pipeline Products
Table 17: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Orthobiologics Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 2: Bone Grafts and Substitutes Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 3: Bone Growth Stimulators Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 4: Cartilage Repair Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 5: Soft Tissue Biologics Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 6: Viscosupplementation Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 7: Orthobiologics Market, France, Volume (Units), 2018-2033
Figure 8: Bone Grafts and Substitutes Market, France, Volume (Units), 2018-2033
Figure 9: Bone Growth Stimulators Market, France, Volume (Units), 2018-2033
Figure 10: Cartilage Repair Market, France, Volume (Units), 2018-2033
Figure 11: Soft Tissue Biologics Market, France, Volume (Units), 2018-2033
Figure 12: Viscosupplementation Market, France, Volume (Units), 2018-2033
Figure 13: Orthobiologics Market, France, Company Share (%) 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sanofi
  • Medtronic Plc
  • Stryker Corp

Related Topics

Related Reports

Cartilage Repair Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 - Product Image

Cartilage Repair Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

  • Report
  • Global
From
Russia Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others - Product Image

Russia Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others

  • Report
  • 50 Pages
  • Russia
From
Orthobiologics Devices and Equipment Global Market Report 2024 - Product Image

Orthobiologics Devices and Equipment Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Orthobiologics Global Market Report 2024 - Product Image

Orthobiologics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Orthobiologics - Global Strategic Business Report - Product Image

Orthobiologics - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From

About the Orthobiologics Market

Orthobiologics is a field of biotechnology that focuses on the development of products and treatments to improve musculoskeletal health. It includes the use of biological materials such as stem cells, growth factors, and proteins to repair, regenerate, and replace damaged or diseased tissues. Orthobiologics is used to treat a variety of musculoskeletal conditions, including fractures, tendon and ligament injuries, and degenerative joint diseases. It is also used to improve the healing of bone and soft tissue after surgery. Orthobiologics is a rapidly growing field, with new products and treatments being developed to improve patient outcomes. It is becoming increasingly important in the treatment of musculoskeletal conditions, as it offers a more natural and less invasive approach than traditional treatments. Some companies in the Orthobiologics market include Acelity, AlloSource, Arthrex, Bioventus, DePuy Synthes, Exactech, Integra LifeSciences, Medtronic, MiMedx, Orthofix, and Stryker. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.